TEXT-EXTRACT 2 filename2.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 DIVISION OF CORPORATION FINANCE ` ` November 2, 2020 Steven J. McGarry Chief Financial Officer SLM Corporation 300 Continental Drive Newark, DE 19713 Re: SLM Corporation Schedule TO-I Filed on October 27, 2020 File No. 005-51535 Dear Mr. McGarry: We have reviewed the above-captioned filing and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your filing and/or by providing the requested information. If you do not believe our comments apply to your facts and circumstances, or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your filing, and any information you provide in response to these comments, we may have additional comments. Schedule TO-I Exhibit (a)(1)(A) Offer to Purchase General 1. We note that the Offer is for up to 2,000,000 shares of the Securities, which, if fully tendered, would comprise 50% of the currently outstanding Securities. We further note your disclosure on pages 11 and 12 indicating that you may acquire Securities that remain outstanding in the future. Notwithstanding your disclosures in response to Items 6(c) and 13 of the Schedule TO, please confirm your understanding that if the Company conducts a subsequent acquisition of the Securities that has a reasonable likelihood or purpose of producing one of the effects enumerated in Rule 13e-3(a)(3)(ii), the Offer could be deemed the first step in a series of transactions that constitute a Rule 13e-3 transaction. See Rule 13e-3(a)(3) and Q&A #4 of Release No. 34-17719. Steven J. McGarry SLM Corporation November 2, 2020 Page | 2 Purpose of the Offer, page 13 2. We note the following statement: The principal purpose of the Offer is to reduce our future dividend payments and to enhance our capital structure. Please revise this statement to provide additional detail clarifying how the Offer would enhance your capital structure. See Items 1006(a) and 1011(c) of Regulation M-A. Please also make any conforming changes to similar statements made elsewhere in the Offer to Purchase. Procedures for Tendering the Securities, page 13 3. We note your statements on page 16 indicating that certain of your determinations and interpretations will be final and binding on all parties. Please revise these statements to remove the implication that shareholders may not challenge your determinations and interpretations in a court of competent jurisdiction. Miscellaneous, page 28 4. We note the following statement: If, after such good faith effort, the Company cannot comply with the applicable law, the Company will not make the Offer to (nor will tenders be accepted from or on behalf of) the holders of Securities in that jurisdiction. While offer materials need not be disseminated into jurisdictions where such a distribution would be impermissible, please remove the implication that tendered Securities will not be accepted from all shareholders. See Rule 13e-4(f)(8)(i) and guidance in Section II.G.1 of Exchange Act Release No. 58597 (September 19, 2008). We remind you that the issuer is responsible for the accuracy and adequacy of its disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please direct any questions to me at (202) 551-8729. Sincerely, /s/ Valian A. Afshar Valian A. Afshar Special Counsel Office of Mergers and Acquisitions cc: John Meade, Esq. Davis Polk & Wardwell LLP Marisa D. Stavenas, Esq. Simpson Thacher & Bartlett LLP